NL-OMON54765
Completed
Phase 4
A prospective, observational, multi-centre study investigating alterations of gut microbiome with its subsequent interaction on the brain-immune-intestine axis in patients with active relapsing remitting Multiple Sclerosis who start with oral treatment. - BIA study
Sint Elisabeth Ziekenhuis0 sites72 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- multiple sclerosis
- Sponsor
- Sint Elisabeth Ziekenhuis
- Enrollment
- 72
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. The subject must give written informed consent
- •2\. Males and females in the age of \>\= 18 and \<\= 60 years
- •3\. Planned start Cladribine treatment within 4 weeks from screening
- •4\. The subject must be prepared to and considered able to follow the protocol
- •during the whole trial period
Exclusion Criteria
- •1\. Has used probiotics within one month prior to start Cladribine
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
A clinical study to establish a database for evaluation of disease progression in adults patients with chronic kidney diseaseHealth Condition 1: null- Chronic Kidney DiseaseCTRI/2012/06/002743Fresenius Kabi Asia Pacific Ltd2,500
Completed
Phase 4
This is an observational study in patients to Profile Chronic Cholestatic Liver Diseases who are prescribed Udiliv for their treatmentHealth Condition 1: null- Chronic Cholestasis Liver DiseaseCTRI/2014/05/004615Abbott India Limited250
Completed
N/A
An observational, multicentre, prospective study to see concordance of detecting EGFR mutation by circulating tumour free DNA versus tissues biopsy in Non small cell lung cancerHealth Condition 1: C342- Malignant neoplasm of middle lobe,bronchus or lungHealth Condition 2: null- Non-small cell lung cancerCTRI/2018/08/015290AstraZeneca Pharma India Ltd245
Completed
N/A
An observational multicenter study comparing Tenecteplase assisted Percutaneous Coronary Intervention (PCI) versus primary PCI in Indian patients with ST elevation Myocardial InfarctioHealth Condition 1: null- Patients with acute STEMI who are to be treated with primary PCI/pharmacoinvasive therapy within 12 hours of symptoms onset will be included.CTRI/2011/08/001950STEMI India Charitable Trust200
Completed
N/A
A multicenter, prospective, observational study evaluation the learning effect of an e-learning system-based teaching method on biliary cannulation for native papilla in ERCPJPRN-UMIN000044223Iwata city hospital12